A prospective study to determine the relationship of serum uric acid level to maternal and perinatal outcomes in patients with hypertensive disorders of pregnancy

Jhelum Saurabh; Kirti Anima Kerketta; Shama Parween; Farhat Mazhari

doi:10.18203/2320-1770.ijrcog20263446

Authors

Jhelum Saurabh Department of Obstetrics and Gynecology, Kurji Holy Family Hospital, Patna, Bihar, India
Kirti Anima Kerketta Department of Obstetrics and Gynaecology, Bokaro General Hospital, Bokaro Steel City, Jharkhand, India
Shama Parween Department of Obstetrics and Gynaecology, Bokaro General Hospital, Bokaro Steel City, Jharkhand, India
Farhat Mazhari Department of Obstetrics and Gynaecology, Bokaro General Hospital, Bokaro Steel City, Jharkhand, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20263446

Keywords:

Pre-eclampsia, LSCS, Eclampsia, Uric acid

Abstract

Background: To study maternal and fetal outcomes in patients with hypertensive disorders of pregnancy (According to American College of Obstetrician and Gynaecologists) by the estimation of serum uric acid levels.

Methods: This is a prospective observational study conducted at tertiary hospital in Bokaro Steel city, Jharkhand over a period of 18 months. During this period women diagnosed with hypertensive disorders of pregnancy after 20 weeks (ACOG) were included. Their serum uric acid level was estimated and were divided into two groups, Group A with 60 patients with uric acid ≥6 mg/dl and Group B with 60 patients with uric acid ≥6 mg/dl. Maternal and fetal outcomes were analysed to detect differences between the two groups.

Results: In Group A, 20% had gestational hypertension, 18.3% had mild preeclampsia, 41.67% had severe preeclampsia, 10% had preeclampsia superimposed on chronic hypertension and 16.7% had eclampsia. In Group B 5% had gestational hypertension, 70% had mild preeclampsia,18.3% had severe preeclampsia,5 % had preeclampsia superimposed on chronic hypertension and 1.67% had eclampsia. In group A, the mean serum uric acid (Mean±SD) of the patients were 7.3733±1.4087 mg/dl. In group B, the mean serum uric acid (Mean±SD) of the patients was 4.6633±0.6428 mg/dl. LSCS was the most common mode of delivery in group A whereas in group B majority had spontaneous onset of labour and delivered vaginally (p<0.05). Group A had adverse perinatal outcome as compared to Group B (p<0.05). Overall, Group A had adverse overall outcome as compared to Group B.

Conclusion: Maternal hyperuricemia was associated with adverse maternal and perinatal outcomes in women with hypertensive disorders of pregnancy.

References

Shah M R. Hypertensive disorders in pregnancy. 1st edn published by Jaypee. 2007:1-10.

Corton M, Leveno KL, Bloom KL, Spong KI, Dashe JS. Hypertensive disorders of pregnancy. Will Obstetrics. 2014;24:728-9.

Lind T, Godfrey KA, Otun H. Changes in serum uric acid concentration during normal pregnancy. Br Jr of obst and Gyn. 1984;91:128-32.

Mustaphi R, Gopalan S, Dhaliwal L, Sarkar AK. Hyperuricaemia and pregnancy induced hypertension-reappraisal. Ind. J med Sci. 1996(3);50:68-71.

Johsaon RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease. Hypertension. 2003;41:1183-90.

Carter J, Child A. Serum uric acid levels in normal pregnancy. Aust N Z J Obste Gynaecol. 1989;29:313-4.

Powers RW, Bodnar LM, Ness RB, Cooper KM, Gallaher MJ, Frank MP, et al. Uric acidconcentration in early pregnancy among preeclampsia women with gestational hyperuricemia at delivery. Am J Obstet Gynecol. 2006;194:160.

Bainbridge SA, Deng JS, Roberts JM. Increased xanthine oxidase in the skin of preeclamptic women. Reprod Sci. 2009;16(5):468-78.

Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol. 2000;156(1):321-31.

Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta. 2008;29(3):67-72.

Villa L, Robecchi A, Ballabio CB. Physiopathology, clinical manifestations, and treatment of gout. I. Physiopathology and pathogenesis. Ann Rheum Dis. 1958;17(1):9-15.

Brien ME, Duval C, Palacios J, Boufaied I, Hudon-Thibeault AA, Nadeau-Vallée M, et al. Uric acid crystals induce placental inflammation and alter trophoblast function via an IL-1-dependent pathway: implications for fetal growth restriction. J Immunol. 2017;198(1):443-51.

Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C, Bossuyt PM, van der Post JA, von Dadelszen P, et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG. 2012;119(7):778-87.

Bellomo G, Venanzi S, Saronio P, Verdura C, Narducci PL. Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension. 2011;58(4):704-8.

Katz VL, Farmer R, Kuller JA. Preeclampsia into eclampsia: toward a new paradigm. Am J Obstet Gynecol. 2000;182(6):1389-96.

Paula LG, Pinheiro da Costa BE, Hentschke MR, Antonello IC, Luz JH, da Cunha Filho EV, et al. Increased proteinuria and uric acid levels are associated with eclamptic crisis. Pregnancy Hypertens. 2019;15:93-7.

Le TM, Nguyen LH, Phan NL, Le DD, Nguyen HVQ, Truong VQ, et al. Maternal serum uric acid concentration and pregnancy outcomes in women with pre-eclampsia/eclampsia. Int J Gynaecol Obstet. 2019;144(1):21-6.

Tejal P. Relationship of Serum Uric Acid Level to Maternal and Perinatal Outcome in Patients with Hypertensive Disorders of Pregnancy. Gujarat Med J. 2014;69:45-7.

Sachan R, Patel ML, Sachan P, Gaurav A, Singh M, Bansal B. Outcomes in hypertensive disorders of pregnancy in the North Indian population. Int J Womens Health. 2013;5:101-8.

Kumar N, Singh AK, Maini B. Impact of maternal serum uric acid on perinatal outcome in women with hypertensive disorders of pregnancy: A prospective study. Pregnancy Hypertens. 2017;10:220-5.

Gurung SD, Shrestha J, Gauchan E, Subedi A, Shrestha A, Thapa S. Correlation of Maternal Serum Uric Acid Level and Feto-maternal Outcome in Hypertensive Disorder of Pregnancy: A Prospective Study. Nepal J Med Sci. 2022;7(2):13-8.